Yakutia detects H3N2 flu strain amid seasonal respiratory surge
Yakutia detects H3N2 flu strain amid seasonal respiratory surge
Yakutia detects H3N2 flu strain amid seasonal respiratory surge
Health authorities in Yakutia have detected the H3N2 influenza strain among circulating viruses. The discovery comes as the region faces a seasonal rise in respiratory infections. Despite local reports of suspected cases, no confirmed illnesses from this strain have been recorded so far.
The H3N2 strain was identified in Yakutia by the end of the 43rd week of 2025. Rospotrebnadzor's local branch confirmed its presence after influenza viruses, including H3N2, had been circulating since the 41st week. The Vector State Research Center of Virology and Biotechnology later verified the specific strain.
Medical facilities in the region are conducting up to 10,000 weekly tests for influenza and ARVI. While the H3N2 strain has appeared in previous years—2021, 2022, and 2023—no confirmed cases of illness tied to it have been documented in 2025. Rospotrebnadzor also noted a 17% average weekly increase in ARVI cases, consistent with seasonal trends.
Local media had earlier reported suspected cases of 'Hong Kong flu', another name for H3N2. However, authorities clarified that no official diagnoses of the strain have been made in the Republic of Sakha.
The detection of H3N2 in Yakutia follows routine surveillance as respiratory infections rise. Testing remains extensive, with no confirmed illnesses linked to the strain as of now. Authorities continue to monitor the situation closely.
Garlic, Vitamin C, and Chlorophyll Team Up for Heart Health Breakthrough
Could a simple blend of garlic, vitamin C, and chlorophyll be the key to a healthier heart? New findings reveal surprising benefits for blood pressure and beyond.
Chuck Norris, 86, hospitalized after medical emergency in Hawaii
From Walker, Texas Ranger to recent films, Norris never slowed down—until now. Fans worldwide await news after his sudden hospitalization.
Blood Test Breakthrough Could Detect Hidden Artery Disease Years Earlier
A simple blood test could soon reveal invisible plaque buildup—long before it triggers a deadly event. Machine learning cracked the code in 45,000 patients' data.
Eli Lilly's retatrutide shows groundbreaking results in Type 2 diabetes trial
A triple-hormone drug could redefine diabetes care. Early data shows retatrutide outperforms competitors—but will regulators agree?